Form 4: Agilon Health Director Ronald A. Williams Reports Acquisition of Restricted Stock Units

Ronald A. Williams, a director of Agilon Health, Inc., reported the acquisition of 32,119 shares of common stock in the form of restricted stock units on May 29, 2024.

Summary

• On May 29, 2024, Ronald A. Williams, a director of Agilon Health, Inc., acquired 32,119 shares of common stock in the form of restricted stock units.
• These restricted stock units vest in full on May 29, 2025, contingent upon continued service as a director.
• Following this transaction, Williams beneficially owns 3,596,533 shares of Agilon Health, Inc., including restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director generally indicates confidence in the company's prospects, but it's a routine transaction.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units is contingent upon continued service as a director, aligning the director's interests with the long-term performance of the company.

Industry Context

Form 4 filings are routine disclosures that provide transparency into the transactions of company insiders, offering insights into their perspectives on the company's value and prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment as it reflects insider confidence.

Key Dates